ConductScience.org, home

Paper3279

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

Barbeau A and 2 others. Can Med Assoc J, 1976. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease. Papers, record 3279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3279

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.
PubMed
Journal
Can Med Assoc J
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.35
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barbeau AA
2Roy MM
3Kastin AJA J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MSH Release-Inhibiting HormoneMajor topic
Parkinson DiseaseMajor topic
Adult
Aged
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Evaluation
Female
Humans
Middle Aged
Motor Skills

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1238221Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.Pharmacol Biochem Behav1975https://conductscience.org/library/papers/238221PubMed
24364044Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.Pharmacol Biochem Behav1974https://conductscience.org/library/papers/4364044PubMed
34633626Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.Neuroendocrinology1973https://conductscience.org/library/papers/4633626PubMed
44858836DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.Neuroendocrinology1974https://conductscience.org/library/papers/4858836PubMed
55820999Treatment of parkinsonism with levodopa.Arch Neurol1969https://conductscience.org/library/papers/5820999PubMed
64125041M.I.F.: effect on levodopa dyskinesias in man.Lancet1973https://conductscience.org/library/papers/4125041PubMed
74140382Letter: Lithium and M.R.I.H. in tardive dyskinesia.Lancet1974https://conductscience.org/library/papers/4140382PubMed
84216256Melanocyte-stimulating hormone and the hypothalamic hormone which inhibits its release.Adv Neurol1974https://conductscience.org/library/papers/4216256PubMed
94398196Isolation and structure of hypothalamic MSH release-inhibition hormone.Biochem Biophys Res Commun1971https://conductscience.org/library/papers/4398196PubMed
104610443The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man.Neuroendocrinology1974https://conductscience.org/library/papers/4610443PubMed
114614981Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.Eur Neurol1974https://conductscience.org/library/papers/4614981PubMed
124640811Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.Can Med Assoc J1972https://conductscience.org/library/papers/4640811PubMed
134746492Dopamine synthesis: stimulation by a hypothalamic factor.Science1973https://conductscience.org/library/papers/4746492PubMed
144837910Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.Pharmacol Biochem Behav1974https://conductscience.org/library/papers/4837910PubMed
154947365DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).Life Sci I1971https://conductscience.org/library/papers/4947365PubMed
165064701Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).Proc Soc Exp Biol Med1972https://conductscience.org/library/papers/5064701PubMed
175283931Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/5283931PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
38116429Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors.ACS Med Chem Lett2023https://conductscience.org/library/papers/38116429PubMed
18686On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.Naunyn Schmiedebergs Arch Pharmacol1977https://conductscience.org/library/papers/18686PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3279

GET https://conductscience.org/api/papers/v1/3279/authors